2016
-
Finalists announced for CPhI Worldwide Awards
CPhI Worldwide has revealed the finalists for the annual CPhI Pharma Awards.
10/18/2019 -
Pharma in review: trending stories 10/18/19
Most popular Pharma Manufacturing stories from the past seven days.
10/18/2019 -
Merck to lay off 500
Merck said it plans to eliminate approximately 500 jobs largely based out of Pennsylvania along with a small number of New Jersey positions.
10/18/2019 -
FDA calls out Torrent as key contributor to major recall
The FDA has issued a warning letter to Torrent Pharmaceuticals and said the company is at the center of its investigation into a global recall of several blood pressure medications.
10/17/2019 -
Report: Teva may donate $15B in generic drugs to resolve opioid lawsuits
With several major pharma companies staring down the start of a federal trial related to opioids, Teva Pharmaceuticals is reportedly looking to settle by donating $15 billion in drugs.
10/17/2019 -
FDA hits Lupin, Aurobindo and Cipla with Form 483s
The FDA found issues related to cleanliness, out-of-specification results and more after several visits in September.
10/15/2019 -
Sanofi opens next-generation biologics plant in Massachusetts
The French drugmaker is billing the feat as its first digitally-enabled, continuous manufacturing facility.
10/15/2019 -
Takeda sheds Mideast, Africa portfolio
Japan’s largest drugmaker has struck a deal to sell a major part of its portfolio.
10/15/2019 -
Lily migraine drug wins FDA approval
The FDA has given the go-ahead to a new migraine treatment made by Eli Lily and Co.
10/14/2019 -
PhRMA lashes out against Pelosi drug pricing bill
The CEO of the biggest pharma industry lobbying group has warned that Speaker Nancy Pelosi's bill to lower drug prices would have a “devastating” effect on the industry.
10/14/2019 -
Cell therapy startup raises additional $16M in funding
Mogrify announced the initial close of its Series A funding, raising $16 million in this round.
10/14/2019 -
Pharma in review: trending stories 10/11/19
Most popular Pharma Manufacturing stories from the past seven days.
10/11/2019 -
J&J offloads non-opioid analgesic
Neumentum has entered into a global licensing agreement with J&J's Janssen Pharmaceuticals for the rights to novel oral analgesic candidate, JNJ-10450232.
10/11/2019 -
BeiGene builds China biopharma base
BeiGene, announced the completion of Phase 1 of a more than 1,000,000 square foot biomanufacturing facility in Guangzhou, China.
10/11/2019 -
Jury awards man $8B for claims a J&J drug made him grow breasts
A Philadelphia jury has ordered Johnson & Johnson to pay a whopping $8 billion for a claim that the company failed to warn patients about serious side effects associated with an anti-psychotic drug.
10/09/2019 -
Clinuvel cinches FDA nod for rare skin disease drug
For the first time ever, patients in the U.S. with a rare but painful skin disease will have access to an FDA-approved treatment.
10/09/2019 -
Novartis blockbuster eye med wins FDA approval
Beovu injections treat wet age-related macular degeneration that affects 20 million people worldwide, according to the company
10/08/2019 -
Arizona backtracks on Purdue opioid settlement
Last month 24 states and local governments reached a deal that was speculated to be worth more than $10 billion
10/08/2019 -
Glenmark receives FDA warning letter for Baddi plant
Mumbai-based Glenmark Pharmaceuticals has been issued an FDA warning letter for manufacturing issues at its Baddi plant.
10/07/2019 -
Pfizer inks antisense drug deal worth up to $1.5B
Pfizer will front $250 million to gain rights to a phase 2 drug being developed to target a range of major diseases.
10/07/2019